CTIS2023-507241-28-00进行中（未招募）1 期
CB-03-01/39
Cassiopea S.p.A.0 个研究点目标入组 33 人开始时间: 2023年12月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A phase 1 study of FluBHPVE6E7 immunotherapy in patients with HPV16-associated oropharyngeal squamous cell carcinomaTreatment of human papilloma virus (HPV) associated infections and cancersMedDRA version: 20.1Level: LLTClassification code: 10063001Term: Human papilloma virus infection Class: 10021881CTIS2024-514413-36-00Bluesky Immunotherapies GmbH12
招募中
1 期
A Study of NB003 in Patients With Advanced MalignanciesCTIS2022-502401-15-00ingbo Newbay Technology Development Co. Ltd.290
招募中
1 期
First in human clinical trial to evaluate the safety, tolerability and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancerProgressive metastatic solid cancer after failure of established treatment optionsMedDRA version: 20.0Level: LLTClassification code: 10031295Term: Osteosarcoma NOS Class: 10029104MedDRA version: 21.1Level: LLTClassification code: 10006188Term: Breast cancer female NOS Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10024631Term: Liposarcoma NOS Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10042866Term: Synovial sarcoma NOS Class: 10029104MedDRA version: 21.0Level: LLTClassification code: 10010029Term: Colorectal cancer NOS Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10024193Term: Leiomyosarcoma NOS Class: 10029104CTIS2022-503084-15-00Deutsches Krebsforschungszentrum (DKFZ)77
进行中（未招募）
1 期
MK-1403 Single Dose Formulation PK StudyMedDRA version: 20.0Level: LLTClassification code: 10003601Term: Atherosclerosis Class: 10047065AtherosclerosisCTIS2023-507984-20-00Merck Sharp & Dohme LLC16
进行中（未招募）
1 期
Conducting a quality study of the medicinal product - Vortioxetineo therapeutic indication in the current trial with healthy volunteers. The intended indication is for the treatment of major depressive episodes in adultsMedDRA version: 21.1Level: LLTClassification code: 10081270Term: Major depressive disorder Class: 10037175CTIS2023-509946-36-00CCDRD Cooperative Clinical Drug Research and Development AG36